Assessing Therapeutic Efficacy in a Progressive Disease: A Study of Donepezil in Alzheimer's Disease

ISSN： 1172-7047

Source： CNS Drugs, Vol.20, Iss.4, 2006-01, pp. : 311-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study

By Rogers S.L. Doody R.S. Pratt R.D. Ieni J.R.

European Neuropsychopharmacology, Vol. 10, Iss. 3, 2000-05 ,pp. : 195-203

Elsevier

Access to resources Recommend Favorite

Efficacy and Safety of Donepezil in Patients with Alzheimers Disease: Results of a Global, Multinational, Clinical Experience Study

By Boada-Rovira M.

Drugs & Aging, Vol. 21, Iss. 1, 2004-01 ,pp. : 43-53

Adis International

Access to resources Recommend Favorite

Value of donepezil doubtful in Alzheimer's disease

Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

By Rogers S.L. Friedhoff L.T.

European Neuropsychopharmacology, Vol. 8, Iss. 1, 1998-02 ,pp. : 67-75

Elsevier

Access to resources Recommend Favorite

Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer’s disease

By Van Dam Debby Coen Katrien De Deyn Peter

Psychopharmacology, Vol. 197, Iss. 1, 2008-03 ,pp. : 37-43

Springer Publishing Company

Access to resources Recommend Favorite